Use of Antimicrobial Growth Promoters in Food Animals andEnterococcus faeciumResistance to Therapeutic Antimicrobial Drugs in Europe
Open Access
- 1 June 1999
- journal article
- review article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 5 (3), 329-335
- https://doi.org/10.3201/eid0503.990303
Abstract
Supplementing animal feed with antimicrobial agents to enhance growth has been common practice for more than 30 years and is estimated to constitute more than half the total antimicrobial use worldwide. The potential public health consequences of this use have been debated; however, until recently, clear evidence of a health risk was not available. Accumulating evidence now indicates that the use of the glycopeptide avoparcin as a growth promoter has created in food animals a major reservoir of Enterococcus faecium, which contains the high level glycopeptide resistance determinant vanA, located on the Tn1546 transposon. Furthermore, glycopeptide-resistant strains, as well as resistance determinants, can be transmitted from animals to humans. Two antimicrobial classes expected to provide the future therapeutic options for treatment of infections with vancomycin-resistant enterococci have analogues among the growth promoters, and a huge animal reservoir of resistant E. faecium has already been created, posing a new public health problem.Keywords
This publication has 33 references indexed in Scilit:
- Intestinal colonization of a human subject by vancomycin-resistant Enterococcus faeciumClinical Microbiology & Infection, 1999
- Glycopeptide Resistance inEnterococcus faeciumfrom Broilers and Pigs Following Discontinued Use of AvoparcinMicrobial Drug Resistance, 1999
- Detection of thesatAgene and transferability of virginiamycin resistance inEnterococcus faeciumfrom food-animalsFEMS Microbiology Letters, 1998
- Medical Consequences of Antibiotic Use in AgricultureScience, 1998
- Association Between Decreased Susceptibility to a New Antibiotic for Treatment of Human Diseases, Everninomicin (SCH 27899), and Resistance to an Antibiotic Used for Growth Promotion in Animals, AvilamycinMicrobial Drug Resistance, 1998
- Isolation of vancomycin resistant Enterococcus faecium from foodInternational Journal of Food Microbiology, 1997
- Influence of Oral Glycopeptides on the Fecal Flora of Human Volunteers: Selection of Highly Glycopeptide-Resistant EnterococciThe Journal of Infectious Diseases, 1996
- Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in manJournal of Antimicrobial Chemotherapy, 1994
- Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureusFEMS Microbiology Letters, 1992
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988